Industry Sector
New pathway for Innovative tech reviewed by MRHA
New regulatory pathway set to support safe patient access to innovative medical technologies
The MHRA has announced a new regulatory pathway to support safe patient access to innovative medical technologies.
The MHRA, NICE, Health Technology Wales and the Scottish Health Technology Group will operate the Innovative Devices Access Pathway, due for launch later in 2023.
The plan is to work with innovators and bring new products to patients sooner through targeted scientific advice and a clear framework.
Plans are advancing for a new regulatory pathway that facilitates the development of innovative technologies, by providing innovators and manufacturers with a multi-partner support service including targeted scientific advice that brings new products to patients sooner.
Set for launch later in 2023, the IDAP will be run by the MHRA, NICE, and other partners, including the devolved administrations.
The ambition of this new programme is to bring innovative technologies and solutions to the forefront of the National Health Service (NHS), through a new, integrated support service for developers that will include enhanced opportunities for engagement.
The aim is to help take uncertainty out of the route to access, bringing innovative technologies to patients that can transform health outcomes.
The Optical Suppliers Association has devolved a specific working group to assist its members and others involved in technological involvement and will no doubt comment on this story.
